Prova Storytel gratis i 30 dagar Ett universum fyllt av ljudböcker, klicka här för att komma igång

Medscape InDiscussion: Major Depressive Disorder

En podcast av: Medscape

Our American listeners can also listen to Medscape InDiscussion: Major Depressive Disorder at our American site

12 Avsnitt

S2 Episode 6: Utilizing Subtypes and Biotypes for Personalized Treatments of Major Depressive Disorder
Publicerades 2023-07-11

Listen to Medscape InDiscussion: Major Depressive Disorder, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/984454). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Medscape InDiscussion: Major Depressive Disorder

12 Avsnitt

S2 Episode 6: Utilizing Subtypes and Biotypes for Personalized Treatments of Major Depressive Disorder

S2 Episode 5: Predictors of Suicidal Ideation, Suicide Attempt, and Suicide Death in Patients With Major Depressive Disorder

S2 Episode 4: Socioeconomic Predictors of Treatment Outcomes in Patients With Major Depressive Disorder

S2 Episode 3: Sexual Dysfunction Associated With Major Depressive Disorder and Antidepressant Treatment

S2 Episode 2: Race, Equity in Care, and Cultural Competence in Major Depressive Disorder

S2 Episode 1: 'Primary Care First' Model to Screen and Treat Major Depressive Disorder

S1 Episode 6: Psychedelics and Major Depressive Disorder: A Lot of Promise and a Lot of Questions

S1 Episode 5: The Role of Sleep in Major Depressive Disorder

S1 Episode 4: Applying Measurement-Based Care in Major Depressive Disorder

S1 Episode 3: The Role of the Gut Microbiome in Major Depressive Disorder: Where the Research Is Now and Where It Is Headed

S1 Episode 2: The Role of Transcranial Magnetic Stimulation in Major Depressive Disorder

S1 Episode 1: Novel Treatments in Major Depressive Disorder: Ketamine and Esketamine